About Imperagen
Imperagen is a company based in Manchester (United Kingdom) founded in 2021 by Timothy Eyes, Andrew Almond, and Andrew Currin.. Imperagen has raised $4.28 million across 1 funding round from investors including Northern Gritstone and IQ Capital. Imperagen offers products and services including Digital Enzyme Evolution Platform and AI-powered Hotspot Identification. Imperagen operates in a competitive market with competitors including ZYMVOL, Nanosyn and DirectBio, among others.
- Headquarter Manchester, United Kingdom
- Founders Timothy Eyes, Andrew Almond, Andrew Currin
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Imperagen
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$4.28 M (USD)
in 1 rounds
-
Latest Funding Round
$4.28 M (USD), Seed
Aug 02, 2022
-
Investors
Northern Gritstone
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Imperagen
Imperagen offers a comprehensive portfolio of products and services, including Digital Enzyme Evolution Platform and AI-powered Hotspot Identification. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
AI and automation platform accelerates enzyme development for performance improvements.
Identifies key enzyme parts using algorithms for faster experimental predictions.
Funding Insights of Imperagen
Imperagen has successfully raised a total of $4.28M through 1 strategic funding round. The most recent funding activity was a Seed round of $4.28 million completed in August 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $4.3M
-
First Round
First Round
(02 Aug 2022)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2022 | Amount | Seed - Imperagen | Valuation | Northern Gritstone , IQ Capital |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Imperagen
Imperagen has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Northern Gritstone and IQ Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment firm focused on investing in science and technology firms
|
Founded Year | Domain | Location | |
|
Deep tech venture capital firm investing in European and global startups.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Imperagen
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Imperagen
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Imperagen Comparisons
Competitors of Imperagen
Imperagen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ZYMVOL, Nanosyn and DirectBio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of enzyme development & designing, biocatalysis, and protein engineering services
|
|
| domain | founded_year | HQ Location |
Preclinical CRO services in chemistry and biological assays are offered.
|
|
| domain | founded_year | HQ Location |
Pioneers CRISPR-based tools for accurate airborne virus monitoring in various settings.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Imperagen
When was Imperagen founded?
Imperagen was founded in 2021 and raised its 1st funding round 1 year after it was founded.
Where is Imperagen located?
Imperagen is headquartered in Manchester, United Kingdom. It is registered at Manchester, Greater Manchester, United Kingdom.
Who is the current CEO of Imperagen?
Andrew Almond is the current CEO of Imperagen. They have also founded this company.
Is Imperagen a funded company?
Imperagen is a funded company, having raised a total of $4.28M across 1 funding round to date. The company's 1st funding round was a Seed of $4.28M, raised on Aug 02, 2022.
What does Imperagen do?
Imperagen was founded in 2021 in Manchester, United Kingdom, within the biotechnology sector. An enzyme engineering platform is utilized by the company to advance drug development processes. Enzyme products are provided for manufacturing complex drug molecules. Operations extend to laboratory tools, enzyme replacement therapies, and drug delivery systems, supporting various pharmaceutical applications in the region.
Who are the top competitors of Imperagen?
What products or services does Imperagen offer?
Imperagen offers Digital Enzyme Evolution Platform and AI-powered Hotspot Identification.
Who are Imperagen's investors?
Imperagen has 2 investors. Key investors include Northern Gritstone, and IQ Capital.